PR Newswire (Tue, 4:05PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (May 7, 2013)
-
-
PR Newswire (Apr 24, 2013)
-
-
-
-
-
-
-
-
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012
-
-
-
IPO Preview: Regulus TherapeuticsIPOdesktop • Tue, Oct 2, 2012
-
8 IPOs Scheduled For The Week Of October 1IPOdesktop • Tue, Oct 2, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012
-
-
8 IPOs Scheduled For The Week Of October 1IPOdesktop • Tue, Oct 2, 2012
-
-
-
PR Newswire (Tue, 4:05PM)
-
PR Newswire (May 7, 2013)
-
PR Newswire (Apr 24, 2013)
-
at MarketWatch.com (Oct 4, 2012)
RGLS vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases. We were formed in 2007 when Alnylam Pharmaceuticals, Inc., or Alnylam, and Isis Pharmaceuticals, Inc., or Isis, contributed significant... More
